Fig 1.
Schematic flowchart of study design.
Table 1.
Demographic characteristics of the study population with and without HP therapy after matched by age and gender.
Table 2.
Outcomes of the study population.
Table 3.
Multivariate analysis of potential risk factors for the occurrence of CKD in patients with PUD (with and without HP therapy).
Table 4.
Multivariate analysis of potential risk factors for mortality in patients with PUD (with and without HP therapy).
Table 5.
Multivariate analysis of potential risk factors for the occurrence of CKD in patients with PUD (with early and non-early HP therapy).
Table 6.
Multivariate analysis of potential risk factors for mortality in patients with PUD (with early and non-early HP therapy).
Fig 2.
Kaplan-Meier curve for cumulative chronic kidney disease rate between patients with early and non-early Helicobacter pylori therapy.
Fig 3.
Kaplan-Meier curve for cumulative mortality rate between patients with early and non-early Helicobacter pylori therapy.